Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Movement Disorders

• Publication date

  2017-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.26987PMID 28467028PMCID PMC5516529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

  2017cited by this paper
• Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies

  2017cited by this paper
• 18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy

  2017cited by this paper
• Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

  2017cited by this paper
• Which ante mortem clinical features predict progressive supranuclear palsy pathology?

  2017cited by this paper
• Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C

  2016cited by this paper
• An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability

  2016cited by this paper
• Invited review: Neuropathology of tauopathies: principles and practice

  2015cited by this paper
• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

  2015cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  2014cited by this paper
• Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant

  2014influential reference
• The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

  2014influential reference
• Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.

  2013cited by this paper
• An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement

  2013cited by this paper
• Accuracy of the national institute for neurological disorders and stroke/society for progressive supranuclear palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

  2013influential reference
• Development and validation of pedigree classification criteria for frontotemporal lobar degeneration.

  2013cited by this paper
• Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.

  2012cited by this paper
• CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

  2012cited by this paper
• Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia

  2012cited by this paper
• Clinicopathological correlations in corticobasal degeneration

  2011cited by this paper
• Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy

  2011cited by this paper
• Distinctive Features of Saccadic Intrusions and Microsaccades in Progressive Supranuclear Palsy

  2011influential reference
• Does corticobasal degeneration exist? A clinicopathological re-evaluation.

  2010cited by this paper
• What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy‐parkinsonism (PSP‐P)?

  2010cited by this paper
• Behavioral Changes as the Earliest Clinical Manifestation of Progressive Supranuclear Palsy

  2010cited by this paper
• Clinical heterogeneity in progressive supranuclear palsy: Problems of clinical diagnostic criteria of NINDS‐SPSP in a retrospective study of seven Japanese autopsy cases

  2010cited by this paper
• Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study

  2009cited by this paper
• Pure akinesia as initial presentation of PSP: a clinicopathological study.

  2008cited by this paper
• Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy

  2008cited by this paper
• Long lasting pure freezing of gait preceding progressive supranuclear palsy: A clinicopathological study

  2007cited by this paper
• Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy

  2007cited by this paper
• Frontal presentation in progressive supranuclear palsy

  2007cited by this paper
• Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

  2006cited by this paper
• Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration

  2006cited by this paper
• Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome

  2005cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Accuracy of clinical diagnosis of progressive supranuclear palsy

  2004influential reference
• Progressive Nonfluent Aphasia and Subsequent Aphasic Dementia Associated with Atypical Progressive Supranuclear Palsy Pathology

  2003cited by this paper
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cited by this paper
• Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case

  2003cited by this paper
• Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases

  2002cited by this paper
• Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

  1999cited by this paper
• Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

  1999influential reference
• Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

  1997cited by this paper
• Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders

  1996cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996influential reference
• Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

  1996cited by this paper
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper

• Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer's disease.

  2026cites this paper
• Moving beyond the hospital: in-depth characterization of daily-life mobility in patients with atypical Parkinsonian disorders

  2026cites this paper
• The yes-no reversal phenomenon: Prevalence and correlates in mild cognitive impairment and dementia due to neurodegenerative, chronic cerebrovascular, and mixed etiologies.

  2026cites this paper
• Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [18F]PI‐2620 PET

  2026cites this paper
• Multimodal Fusion and Transfer Learning for the Detection of Degenerative Parkinsonisms with Dopamine Transporter SPECT Imaging.

  2026cites this paper
• Hydrocephalus should not be a mandatory exclusion criterion in PSP: Emerging pathologic and clinical evidence urges reconsideration.

  2026cites this paper
• Dementia in Progressive Supranuclear Palsy: A Narrative Review.

  2026cites this paper
• Construct validity of instrumented gait assessments in hospital and daily life mobility in patients with Parkinson’s disease and atypical Parkinson's syndromes: an exploratory study

  2026cites this paper
• Novel Variants in DCTN1 Associated with Perry Disease: A Case Series from a Chinese Parkinsonism Cohort.

  2026cites this paper
• Safety, tolerability and biomarker results of bepranemab in participants with progressive supranuclear palsy: a randomised, multicentre, double-blind, placebo-controlled, phase 1b trial

  2026cites this paper
• Repetitive behaviors in syndromes associated with frontotemporal lobar degeneration.

  2026cites this paper
• Localized Iron Deposition and Shape Changes of Cerebellar Dentate in Progressive Supranuclear Palsy Clinical Variants.

  2026cites this paper
• Standardizing "Rapid": Applying the Clinical Dementia Rating to Define Rapidly Progressive Dementia.

  2026cites this paper
• An eight-year follow-up of the CMSAR: assessing how the new MDS criteria and biomarkers impact diagnostic accuracy

  2026influential citation
• What Is in a Label? The Importance of Clinical Specificity and Challenges of Diagnostic Evolution in Progressive Speech-Language Disorders.

  2026cites this paper
• Combining plasma biomarkers, clinical parameters, and neuroimaging features for differential diagnosis of Parkinson’s disease and atypical parkinsonian syndromes: a multidimensional modeling approach

  2026cites this paper
• CDS-PD: a novel clinical decision support platform for Parkinson’s disease

  2026cites this paper
• Longitudinal Evaluation of Polyneuropathy in Atypical Parkinsonian Syndromes.

  2026cites this paper
• Suicide attempt by a patient with an early phase of progressive supranuclear palsy: a case report.

  2026cites this paper
• Improving access to care through transportation and internet use for patients with atypical parkinsonism: A pilot study.

  2026cites this paper
• Role of Respiratory Pressure in Swallowing Function and Aspiration Risk in Parkinsonism.

  2026cites this paper
• Short tandem repeat expansions in patients with neurodegenerative dementia.

  2026cites this paper
• Dementia with Lewy bodies and additional progressive supranuclear palsy presenting with early postural instability and frequent falls: an autopsy case.

  2026cites this paper
• Cholinergic substrates of gait and postural impairments in Progressive Supranuclear Palsy

  2026cites this paper
• Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy.

  2026cites this paper
• Subtracting First Principal Component May Improve 4R Tau Detectability on [18F]Flortaucipir Tau PET.

  2026cites this paper
• Voice and Speech in Atypical Parkinsonian Disorders.

  2026cites this paper
• Wernicke’s encephalopathy unmasking progressive supranuclear palsy and Alzheimer’s pathology: a diagnostic challenge in an older adult

  2026cites this paper
• Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

  2026cites this paper
• Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptoms

  2026cites this paper
• Dementia with lewy bodies and Alzheimer´s Disease overlap syndrome with PSP-like phenotype caused by co-pathologies – a case report

  2026influential citation
• The Journal at Forty: A Proud Legacy and a Look to the Future

  2026cites this paper
• Rapidly progressive dysphagia and vertical supranuclear gaze palsy: a key diagnostic clue for progressive supranuclear palsy in Levodopa-Resistant parkinsonism

  2026cites this paper
• Understanding the multifaceted nature of quality of life in dementia using a transdiagnostic network analysis approach.

  2026cites this paper
• Association of Alzheimer’s disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study

  2026cites this paper
• Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration

  2026cites this paper
• Multi-model Diffusion MRI Signatures in Atypical Parkinsonian Disorders

  2026cites this paper
• Factors associated with epileptiform discharges in patients visiting a memory clinic: A retrospective study.

  2026cites this paper
• Mitochondrial D-loop region methylation differentiates Parkinson's disease from atypical parkinsonism and Parkinson's disease dementia.

  2026cites this paper
• Blood-based AT(N) biomarkers for Alzheimer’s disease and frontotemporal lobar degeneration in Latin America

  2026cites this paper
• Cutaneous α-Synuclein Pathology as a Differential Marker: A Histological and Statistical Comparison across Neurodegenerative Disease Groups

  2026cites this paper
• Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia

  2026cites this paper
• [MRI in neurodegenerative Parkinsonian syndromes].

  2026cites this paper
• Optical coherence tomography findings in multiple system atrophy: insights into disease diagnosis, clinical correlations, and dopaminergic degeneration

  2026cites this paper
• Deep learning for FDG-PET classification in patients with Alzheimer’s disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity

  2026cites this paper
• Transcranial Sonography in the Examination of Atypical Parkinsonian Syndromes

  2026cites this paper
• Frequency of dementia with lewy bodies in a large memory clinic in Colombia: Results from a 6-month cross-sectional study using the lewy body composite risk score.

  2026cites this paper
• Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases

  2026cites this paper
• Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.

  2026cites this paper
• Real-world evaluation of Armstrong's criteria in corticobasal degeneration: Phenotypic overlap and diagnostic challenges.

  2026cites this paper
• Intérêt de l’étude des mouvements oculaires dans les maladies neurodégénératives

  2026cites this paper
• Executive anosognosia in progressive supranuclear palsy versus Parkinson’s disease

  2026cites this paper
• Reduced synaptic density in patients with progressive supranuclear palsy: An 18F-SynVest-1 PET study.

  2026cites this paper
• Retinal Thickness Profiles in Parkinsonian Syndromes: Discerning Parkinson’s Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy via Optical Coherence Tomography

  2026cites this paper
• Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy

  2025cites this paper
• Magnetic Resonance Imaging in the Neuroimaging of Progressive Supranuclear Palsy—Parkinsonism Predominant: Limitations and Strengths in Clinical Evaluation

  2025cites this paper
• HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance

  2025cites this paper
• Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes

  2025cites this paper
• Clinical utility of cerebrospinal fluid Alzheimer’s disease biomarkers in the diagnostic workup of complex patients with cognitive impairment

  2025cites this paper
• Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers—A Narrative Review

  2025influential citation
• A radiomics approach to distinguish Progressive Supranuclear Palsy Richardson's syndrome from other phenotypes starting from MR images

  2025cites this paper
• Tongue strength in progressive supranuclear palsy.

  2025cites this paper
• Criminal Behavior in Early Onset Neurodegenerative Diseases

  2025cites this paper
• Selective cellular and regional vulnerability in frontotemporal lobar degeneration: a scoping review

  2025cites this paper
• Integrated management of atypical parkinsonism: a home-based patient-centered healthcare delivery based on telenursing—the IMPACT study protocol

  2025cites this paper
• Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes

  2025cites this paper
• Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years

  2025cites this paper
• Assessing the Big Five personality traits in presymptomatic and symptomatic C9orf72-related frontotemporal dementia using the Dutch Personality Inventory for DSM-5 (PID-5-NL).

  2025cites this paper
• Galvanic vestibular stimulation for postural rehabilitation in neurological disorders: a systematic review

  2025influential citation
• Does Midbrain Atrophy Distinguish Progressive Supranuclear Palsy from Frontotemporal Dementia?

  2025cites this paper
• Investigation of the significance of quantitative MRI parameters in differentiating PSP from MSA patients.

  2025cites this paper
• I-Beam Sign in Progressive Supranuclear Palsy.

  2025cites this paper
• Age doesn't matter: Very late-onset Niemann-Pick type C disease presenting as a PSP Richardson syndrome mimic.

  2025cites this paper
• Deep brain stimulation in progressive supranuclear palsy: a dead-end story? A narrative review

  2025cites this paper
• The Significance of High-Density Lipoprotein-Derived Inflammatory Parameters in Atypical Parkinsonisms—Pilot Study

  2025cites this paper
• Supranuclear Disorders of Eye Movements

  2025cites this paper
• Automated Imaging Differentiation for Parkinsonism

  2025cites this paper
• Multinomial logistic regression algorithm for the classification of patients with parkinsonisms

  2025cites this paper
• Exploring the origins of frequent tau-PET signal in vermal and adjacent regions

  2025cites this paper
• Case report: Behavioral variant FTD confounding a language variant FTD in a case of PSP-CBS

  2025cites this paper
• Etiologies of Rapidly Progressive Dementia: A Cross‐Sectional Multicentric Tertiary Hospital Study

  2025cites this paper
• Joint examination of reflexive vertical saccades and small involuntary fixational saccades improves the classification of patients with progressive supranuclear palsy (PSP): a ROC study

  2025cites this paper
• Identifying reversible psychiatric dementia mimics in new memory clinic outpatients

  2025cites this paper
• Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer’s disease and other neurodegenerative dementias in a large Chinese cohort

  2025cites this paper
• Head position control strategies in progressive Supranuclear Palsy versus Idiopathic Parkinson’s Disease during dynamic-on-static platform tilt

  2025cites this paper
• Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration

  2025cites this paper
• A case of spinocerebellar ataxia type 8 with clinical manifestations as Parkinson's disease.

  2025cites this paper
• Gait analysis in mixed reality for Parkinson's disease assessment

  2025cites this paper
• Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data‐driven clinicopathologic study

  2025cites this paper
• Radiomics analysis of substantia nigra on multi-echo susceptibility map-weighted imaging for differentiating Parkinson’s disease from atypical parkinsonian syndromes

  2025cites this paper
• A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease

  2025cites this paper
• Distinct sensorimotor cough features in a cohort of Progressive Supranuclear Palsy

  2025influential citation
• Autonomic dysfunction in progressive supranuclear Palsy: A retrospective study

  2025cites this paper
• Taste impairment in patients with Parkinsonism

  2025cites this paper
• Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies

  2025cites this paper
• Unmasking the Unexpected: FIG4‐Related Disorder Presenting with Progressive Supranuclear Palsy‐Like Features

  2025cites this paper
• Tau biomarkers for neurodegenerative diseases: Current state and perspectives.

  2025cites this paper
• Hemispheric asymmetry in neurodegenerative diseases.

  2025cites this paper
• Sleep Phenotypes of α-Synucleinopathies and Tauopathies with Parkinsonism

  2025cites this paper
• Annual percentage change of MR Parkinsonism index in progressive supranuclear palsy: a feasibility study

  2025influential citation